Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
2.200
0.00 (0.00%)
Jun 26, 2026, 4:00 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$9,534
Profits / Employee
-$852,716
Market Cap
478.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoDyn | 13 |
| Northwest Biotherapeutics | 105 |
| Vaxart | 65 |
| Cell Source | 1 |
| Nuo Therapeutics | 10 |
| Vicapsys Life Sciences | 2 |
Silence Therapeutics News
- 5 days ago - Cantor starts ‘materially undervalued’ Silence Therapeutics at Overweight - TheFly
- 5 days ago - Silence Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 6 days ago - Silence Therapeutics Slides: Corporate presentation - Filings
- 18 days ago - Silence Therapeutics highlights follow-up data on divesiran at EHA 2026 - TheFly
- 18 days ago - Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera - Business Wire
- 25 days ago - Silence Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Silence Therapeutics to Participate in Jefferies Global Healthcare Conference - Business Wire
- 5 weeks ago - Silence Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts